A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination
- PMID: 37561928
- DOI: 10.1111/jdv.19414
A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination
References
REFERENCES
-
- Gambichler T, Boms S, Susok L, Dickel H, Finis C, Rached NA, et al. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol. 2022;36(2):172-180. https://doi.org/10.1111/jdv.17744
-
- Akoglu G. Pemphigus vulgaris after SARS-CoV-2 vaccination: a case with new-onset and two cases with severe aggravation. Dermatol Ther. 2022;35(5):e15396. https://doi.org/10.1111/dth.15396
-
- Hébert V, Boulard C, Houivet E, Lehembre SD, Borradori L, Torre RD, et al. French study group on autoimmune bullous skin diseases; autoimmune bullous skin disease task force of the European academy of dermatology and venereology. Large international validation of ABSIS and PDAI pemphigus severity scores. J Invest Dermatol. 2019;139(1):31-37. https://doi.org/10.1016/j.jid.2018.04.042
-
- Joly P, Horvath B, Patsatsi Α, Uzun S, Bech R, Beissert S, et al. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV). J Eur Acad Dermatol Venereol. 2020;34(9):1900-1913. https://doi.org/10.1111/jdv.16752
-
- Murrell DF, Peña S, Joly P, Marinovic B, Hashimoto T, Diaz LA, et al. Diagnosis and management of pemphigus: recommendations of an international panel of experts. J Am Acad Dermatol. 2020;82(3):575-585.e1. https://doi.org/10.1016/j.jaad.2018.02.021
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous